Advestra advises Novartis on the issuance of CHF 2.2 bn bonds

Novartis AG suc­cess­fully placed CHF bonds in the aggreg­ate prin­cip­al amount of CHF 2.2 bn in five tranches as fol­lows: The first tranche was issued in the prin­cip­al amount of CHF 650 mio., with a coupon of 1.60% and a matur­ity date 2027, the second tranche in the prin­cip­al amount of CHF 435 mio., with a coupon of 1.65% and a matur­ity date of 2031, the third tranche in the prin­cip­al amount of CHF 645 mio., with a coupon of 1.75% and a matur­ity date of 2034, the fourth tranche in the prin­cip­al amount of CHF 280 mio., with a coupon of 1.85% and a matur­ity date of 2040 as well as the fifth tranche in the prin­cip­al amount of CHF 190 mio., with a coupon of 1.85% and a matur­ity date of 2049.

UBS, BNP Pari­bas (Suisse) SA and Deutsche Bank Aktiengesell­schaft acted as Joint Lead Man­agers and Zürch­er Kan­ton­al­bank acted as Co-Man­ager in this transaction.

Advestra acted as leg­al coun­sel to Novartis. The team included Annette Weber and Valérie Bayard (both Cap­it­al Mar­kets) as well as Céline Mar­tin (Tax).